STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Clinical trials for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE trials appear
Sign up with your email to follow new studies for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for chinese patients with severe transplant complication
Disease control Recruiting nowThis study tests the drug ruxolitinib in Chinese patients aged 12 and older who have a serious complication after a stem cell transplant called graft-versus-host disease (GvHD) that did not improve with steroids. The goal is to see if ruxolitinib can control the disease by reduci…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:08 UTC
-
Ancient heat therapy may ease Life-Threatening transplant complication
Symptom relief Recruiting nowThis study tests whether moxibustion—a traditional therapy that burns herbs near the skin—can help people with severe gut problems after a stem cell transplant. About 42 patients whose graft-versus-host disease did not respond to steroids will receive standard drugs plus daily mo…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC